REPLIGEN CORP: net income or loss
Net income or loss for REPLIGEN CORP. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All REPLIGEN CORP financial histories
What this measure means
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
Exact concept: us-gaap:NetIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2009-04-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 48,894,000 | USD | 2026-02-26 | 10-K · 0001193125-26-076528 |
| 2024-01-01 | 2024-12-31 | -25,514,000 | USD | 2026-02-26 | 10-K · 0001193125-26-076528 |
| 2023-01-01 | 2023-12-31 | 35,596,000 | USD | 2026-02-26 | 10-K · 0001193125-26-076528 |
| 2022-01-01 | 2022-12-31 | 185,959,000 | USD | 2025-03-14 | 10-K · 0000950170-25-038999 |
| 2021-01-01 | 2021-12-31 | 128,291,000 | USD | 2024-11-18 | 10-K/A · 0000950170-24-127842 |
| 2020-01-01 | 2020-12-31 | 59,926,000 | USD | 2023-02-22 | 10-K · 0000950170-23-003793 |
| 2019-01-01 | 2019-12-31 | 21,411,000 | USD | 2022-02-17 | 10-K · 0000950170-22-001430 |
| 2018-01-01 | 2018-12-31 | 16,617,000 | USD | 2021-02-24 | 10-K · 0001193125-21-054675 |
| 2017-01-01 | 2017-12-31 | 28,353,000 | USD | 2020-02-26 | 10-K · 0001193125-20-050136 |
| 2016-01-01 | 2016-12-31 | 11,681,000 | USD | 2019-03-01 | 10-K · 0001193125-19-060645 |
| 2015-01-01 | 2015-12-31 | 9,345,000 | USD | 2018-02-22 | 10-K · 0001193125-18-054262 |
| 2014-01-01 | 2014-12-31 | 8,170,000 | USD | 2017-02-23 | 10-K · 0001193125-17-054220 |
| 2013-01-01 | 2013-12-31 | 16,093,000 | USD | 2016-02-25 | 10-K · 0001193125-16-478518 |
| 2012-01-01 | 2012-12-31 | 14,156,037 | USD | 2015-03-17 | 10-K · 0001193125-15-095569 |
| 2011-01-01 | 2011-12-31 | -1,612,625 | USD | 2014-03-14 | 10-K · 0001193125-14-099241 |
| 2010-04-01 | 2011-03-31 | -43,509 | USD | 2013-03-15 | 10-K · 0001193125-13-109050 |
| 2009-04-01 | 2010-03-31 | -4,063,844 | USD | 2012-03-15 | 10-K · 0001193125-12-116662 |
Related financial histories
- REPLIGEN CORP: total assets
- REPLIGEN CORP: total liabilities
- REPLIGEN CORP: stockholders equity
- REPLIGEN CORP: cash and cash equivalents
- REPLIGEN CORP: operating cash flow
- REPLIGEN CORP: capital expenditure payments
- REPLIGEN CORP: revenue
- REPLIGEN CORP: financing cash flow
- REPLIGEN CORP: investing cash flow
- REPLIGEN CORP: retained earnings or deficit
- REPLIGEN CORP: basic weighted-average shares
- REPLIGEN CORP: diluted weighted-average shares
- REPLIGEN CORP: basic earnings per share
- REPLIGEN CORP: diluted earnings per share
- REPLIGEN CORP: income tax expense or benefit
- REPLIGEN CORP: net property, plant and equipment
- REPLIGEN CORP: share-based compensation expense
- REPLIGEN CORP: operating income or loss
- REPLIGEN CORP: current assets
- REPLIGEN CORP: interest expense
- REPLIGEN CORP: current liabilities
- REPLIGEN CORP: current accounts payable
- REPLIGEN CORP: goodwill carrying amount
- REPLIGEN CORP: net finite-lived intangible assets
- REPLIGEN CORP: net current accounts receivable
- REPLIGEN CORP: common-stock repurchase payments
- REPLIGEN CORP: net inventory
- REPLIGEN CORP: selling, general and administrative expense
- REPLIGEN CORP: research and development expense
Inspect the source
- Entity
- REPLIGEN CORP / CIK 0000730272
- Captured
- 2026-09-19T15:00:36.697Z
- SEC response SHA-256
bd2d478eac88ec3e8a9d515f4560d1b9798ad6bae67a9a97fb330c10ebce8ca3
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000730272.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))